Vhteam.Com > Feeds > Class 1 new drug research and development pipeline quick reference in China - east sun medicine

Class 1 new drug research and development pipeline quick reference in China - east sun medicine

中文版 Comment
Class 1 new drug research and development pipeline quick reference in China - east sun medicine
East sun medicine is a focus on antiviral, endocrine, diseases such as cardiovascular, anti-tumor therapeutic areas in terms of product research and development, production and sales of pharmaceutical enterprises, is the east sunshine group's domestic preparation platform; Is China's first independent research and development, independent registered, at the same time by the FDA, the European Union, the world health organization (who), Australia, China CFDA multiple GMP certification preparation finished medicine production enterprises; Its predecessor for yichang Yangtze river pharmaceutical co., LTD., on May 11, 2015, restructured into yichang east sun Yangtze river pharmaceutical co., LTD., and on December 29, 2015 main board listing in Hong Kong (stock code: 1558). East sun medicine development (source: east sunshine 2016 annual report) east sun medicine has a strong r&d team, led by the international experts, involving chemical, biological, toxicology, core r&d team...
The results from the Machine Translation
Read More
Relate
Hots
DayWeekMonth